{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:13:08Z","timestamp":1783077188858,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI020211"],"award-info":[{"award-number":["AI020211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1007\/s00430-019-00617-6","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:25:06Z","timestamp":1558560306000},"page":"543-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Caspase-8 restricts natural killer cell accumulation during MCMV Infection"],"prefix":"10.1007","volume":"208","author":[{"given":"Yanjun","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa P.","family":"Daley-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Potempa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis L.","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Mocarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"617_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495\u2013502","journal-title":"Nat Immunol"},{"key":"617_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri3044","volume":"11","author":"JC Sun","year":"2011","unstructured":"Sun JC, Lanier LL (2011) NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol 11:645\u2013657","journal-title":"Nat Rev Immunol"},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1073\/pnas.092258599","volume":"99","author":"HR Smith","year":"2002","unstructured":"Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826\u20138831","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR4","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","volume":"200","author":"G Picarda","year":"2018","unstructured":"Picarda G, Benedict CA (2018) Cytomegalovirus: shape-shifting the immune system. J Immunol 200:3881\u20133889","journal-title":"J Immunol"},{"key":"617_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44\u201349","journal-title":"Science"},{"key":"617_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"JC Sun","year":"2009","unstructured":"Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557\u2013561","journal-title":"Nature"},{"key":"617_CR7","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","volume":"104","author":"M Guma","year":"2004","unstructured":"Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104:3664\u20133671","journal-title":"Blood"},{"key":"617_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/504719","volume":"194","author":"M Guma","year":"2006","unstructured":"Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, Lopez-Botet M (2006) Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94\/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 194:38\u201341","journal-title":"J Infect Dis"},{"key":"617_CR9","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","volume":"108","author":"S Lopez-Verges","year":"2011","unstructured":"Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL (2011) Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 108:14725\u201314732","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2016.11.003","volume":"44","author":"VC Lam","year":"2017","unstructured":"Lam VC, Lanier LL (2017) NK cells in host responses to viral infections. Curr Opin Immunol 44:43\u201351","journal-title":"Curr Opin Immunol"},{"key":"617_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.4049\/jimmunol.1402001","volume":"194","author":"S Madera","year":"2015","unstructured":"Madera S, Sun JC (2015) Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion. J Immunol 194:1408\u20131412","journal-title":"J Immunol"},{"issue":"1949\u20131957","key":"617_CR12","first-page":"e1946","volume":"24","author":"CD Geary","year":"2018","unstructured":"Geary CD, Krishna C, Lau CM, Adams NM, Gearty SV, Pritykin Y, Thomsen AR, Leslie CS, Sun JC (2018) Non-redundant ISGF3 components promote NK cell survival in an auto-regulatory manner during viral infection. Cell Rep 24(1949\u20131957):e1946","journal-title":"Cell Rep"},{"issue":"1172\u20131182","key":"617_CR13","first-page":"e1176","volume":"48","author":"NM Adams","year":"2018","unstructured":"Adams NM, Lau CM, Fan X, Rapp M, Geary CD, Weizman OE, Diaz-Salazar C, Sun JC (2018) Transcription factor IRF8 orchestrates the adaptive natural killer cell response. Immunity 48(1172\u20131182):e1176","journal-title":"Immunity"},{"key":"617_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1084\/jem.20150712","volume":"213","author":"S Madera","year":"2016","unstructured":"Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC (2016) Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med 213:225\u2013233","journal-title":"J Exp Med"},{"key":"617_CR15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.156.3.1138","volume":"156","author":"JS Orange","year":"1996","unstructured":"Orange JS, Biron CA (1996) An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156:1138\u20131142","journal-title":"J Immunol"},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","volume":"169","author":"KB Nguyen","year":"2002","unstructured":"Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169:4279\u20134287","journal-title":"J Immunol"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.4049\/jimmunol.1700799","volume":"199","author":"T Nabekura","year":"2017","unstructured":"Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL (2017) Cutting Edge: NKG2D signaling enhances NK cell responses but alone is insufficient to drive expansion during mouse cytomegalovirus infection. J Immunol 199:1567\u20131571","journal-title":"J Immunol"},{"key":"617_CR18","first-page":"404","volume":"3","author":"S Kurtulus","year":"2012","unstructured":"Kurtulus S, Tripathi P, Hildeman DA (2012) Protecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development. Front Immunol 3:404","journal-title":"Front Immunol"},{"key":"617_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2570","volume":"9","author":"P Bouillet","year":"2009","unstructured":"Bouillet P, O\u2019Reilly LA (2009) CD95, BIM and T cell homeostasis. Nat Rev Immunol 9:514\u2013519","journal-title":"Nat Rev Immunol"},{"key":"617_CR20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1084\/jem.20132459","volume":"211","author":"G Min-Oo","year":"2014","unstructured":"Min-Oo G, Bezman NA, Madera S, Sun JC, Lanier LL (2014) Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J Exp Med 211:1289\u20131296","journal-title":"J Exp Med"},{"key":"617_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.it.2013.02.005","volume":"34","author":"G Min-Oo","year":"2013","unstructured":"Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL (2013) NK cells: walking three paths down memory lane. Trends Immunol 34:251\u2013258","journal-title":"Trends Immunol"},{"key":"617_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.virol.2015.03.016","volume":"479\u2013480","author":"ES Mocarski","year":"2015","unstructured":"Mocarski ES, Guo H, Kaiser WJ (2015) Necroptosis: the Trojan horse in cell autonomous antiviral host defense. Virology 479\u2013480:160\u2013166","journal-title":"Virology"},{"key":"617_CR23","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4049\/jimmunol.1302426","volume":"192","author":"ES Mocarski","year":"2014","unstructured":"Mocarski ES, Kaiser WJ, Livingston-Rosanoff D, Upton JW, Daley-Bauer LP (2014) True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol 192:2019\u20132026","journal-title":"J Immunol"},{"key":"617_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri3131","volume":"12","author":"ES Mocarski","year":"2012","unstructured":"Mocarski ES, Upton JW, Kaiser WJ (2012) Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 12:79\u201388","journal-title":"Nat Rev Immunol"},{"key":"617_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers B, Green DR (2017) Caspase-8: regulating life and death. Immunol Rev 277:76\u201389","journal-title":"Immunol Rev"},{"key":"617_CR26","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.4049\/jimmunol.1001918","volume":"186","author":"F Masson","year":"2011","unstructured":"Masson F, Kupresanin F, Mount A, Strasser A, Belz GT (2011) Bid and Bim collaborate during induction of T cell death in persistent infection. J Immunol 186:4059\u20134066","journal-title":"J Immunol"},{"key":"617_CR27","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.4049\/jimmunol.1800110","volume":"201","author":"Y Feng","year":"2018","unstructured":"Feng Y, Livingston-Rosanoff D, Roback L, Sundararajan A, Speck SH, Mocarski ES, Daley-Bauer LP (2018) Remarkably robust antiviral immune response despite combined deficiency in caspase-8 and RIPK3. J Immunol 201:2244\u20132255","journal-title":"J Immunol"},{"key":"617_CR28","doi-asserted-by":"crossref","unstructured":"Feng Y, Daley-Bauer LP, Roback L, Guo H, Koehler HS, Potempa M, Lanier LL, Mocarski ES (2019) Caspase-8 restricts antiviral CD8 T cell hyperaccumulation. Proc Natl Acad Sci USA (In press)","DOI":"10.1073\/pnas.1904319116"},{"key":"617_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature01063","volume":"419","author":"HJ Chun","year":"2002","unstructured":"Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395\u2013399","journal-title":"Nature"},{"key":"617_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1104765","volume":"307","author":"H Su","year":"2005","unstructured":"Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M (2005) Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307:1465\u20131468","journal-title":"Science"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368\u2013372","journal-title":"Nature"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.1401857111","volume":"111","author":"WJ Kaiser","year":"2014","unstructured":"Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C, Sundararajan A, Guo H, Roback L, Speck SH, Bertin J, Gough PJ, Balachandran S, Mocarski ES (2014) RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 111:7753\u20137758","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B, Ouellette M, King BW, Wisnoski D, Lakdawala AS, DeMartino MP, Casillas LN, Haile PA, Sehon CA, Marquis RW, Upton J, Daley-Bauer LP, Roback L, Ramia N, Dovey CM, Carette JE, Chan FK, Bertin J, Gough PJ, Mocarski ES, Kaiser WJ (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56:481\u2013495","journal-title":"Mol Cell"},{"key":"617_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/ni714","volume":"2","author":"AO Dokun","year":"2001","unstructured":"Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2:951\u2013956","journal-title":"Nat Immunol"},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1371\/journal.ppat.0030123","volume":"3","author":"SH Robbins","year":"2007","unstructured":"Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M (2007) Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 3:e123","journal-title":"PLoS Pathog"},{"key":"617_CR36","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1128\/JVI.06042-11","volume":"86","author":"M Mitrovic","year":"2012","unstructured":"Mitrovic M, Arapovic J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotic A, Reddehase MJ, Jonjic S (2012) The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J Virol 86:2165\u20132175","journal-title":"J Virol"},{"key":"617_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ni880","volume":"4","author":"DM Andrews","year":"2003","unstructured":"Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4:175\u2013181","journal-title":"Nat Immunol"},{"key":"617_CR38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1084\/jem.20091193","volume":"207","author":"DM Andrews","year":"2010","unstructured":"Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, van der Most RG, Scalzo AA, Smyth MJ, Degli-Esposti MA (2010) Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med 207:1333\u20131343","journal-title":"J Exp Med"},{"key":"617_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coi.2018.05.013","volume":"54","author":"CM Lau","year":"2018","unstructured":"Lau CM, Sun JC (2018) The widening spectrum of immunological memory. Curr Opin Immunol 54:42\u201349","journal-title":"Curr Opin Immunol"},{"key":"617_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/cdd.2014.118","volume":"22","author":"S Kurtulus","year":"2015","unstructured":"Kurtulus S, Sholl A, Toe J, Tripathi P, Raynor J, Li KP, Pellegrini M, Hildeman DA (2015) Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins. Cell Death Differ 22:174\u2013184","journal-title":"Cell Death Differ"},{"key":"617_CR41","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.4049\/jimmunol.179.8.5291","volume":"179","author":"AF Arechiga","year":"2007","unstructured":"Arechiga AF, Bell BD, Leverrier S, Weist BM, Porter M, Wu Z, Kanno Y, Ramos SJ, Ong ST, Siegel R, Walsh CM (2007) A Fas-associated death domain protein\/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. J Immunol 179:5291\u20135300","journal-title":"J Immunol"},{"key":"617_CR42","doi-asserted-by":"publisher","first-page":"e26423","DOI":"10.7554\/eLife.26423","volume":"6","author":"A Marcais","year":"2017","unstructured":"Marcais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Blery M, Vivier E, Bryceson Y, Thaunat O, Walzer T (2017) High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors. Elife 6:e26423","journal-title":"Elife"},{"key":"617_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Marcais","year":"2014","unstructured":"Marcais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, Rabilloud J, Mayol K, Tavares A, Bienvenu J, Gangloff YG, Gilson E, Vivier E, Walzer T (2014) The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol 15:749\u2013757","journal-title":"Nat Immunol"},{"key":"617_CR44","doi-asserted-by":"publisher","first-page":"17463","DOI":"10.1073\/pnas.0808043105","volume":"105","author":"IL Ch\u2019en","year":"2008","unstructured":"Ch\u2019en IL, Beisner DR, Degterev A, Lynch C, Yuan J, Hoffmann A, Hedrick SM (2008) Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci USA 105:17463\u201317468","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-065X.2010.00918.x","volume":"236","author":"SM Hedrick","year":"2010","unstructured":"Hedrick SM, Ch\u2019en IL, Alves BN (2010) Intertwined pathways of programmed cell death in immunity. Immunol Rev 236:41\u201353","journal-title":"Immunol Rev"},{"key":"617_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20110251","volume":"208","author":"IL Ch\u2019en","year":"2011","unstructured":"Ch\u2019en IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM (2011) Mechanisms of necroptosis in T cells. J Exp Med 208:633\u2013641","journal-title":"J Exp Med"},{"key":"617_CR47","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","volume":"9","author":"M Juilland","year":"2018","unstructured":"Juilland M, Thome M (2018) Holding all the CARDs: how MALT1 controls CARMA\/CARD-dependent signaling. Front Immunol 9:1927","journal-title":"Front Immunol"},{"key":"617_CR48","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.4049\/jimmunol.175.12.7800","volume":"175","author":"AF Arechiga","year":"2005","unstructured":"Arechiga AF, Bell BD, Solomon JC, Chu IH, Dubois CL, Hall BE, George TC, Coder DM, Walsh CM (2005) Cutting edge: fADD is not required for antigen receptor-mediated NF-kappaB activation. J Immunol 175:7800\u20137804","journal-title":"J Immunol"},{"key":"617_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1478-811X-9-7","volume":"9","author":"M Paulsen","year":"2011","unstructured":"Paulsen M, Janssen O (2011) Pro- and anti-apoptotic CD95 signaling in T cells. Cell Commun Signal 9:7","journal-title":"Cell Commun Signal"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-019-00617-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T20:41:40Z","timestamp":1694896900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-019-00617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":49,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2019,8,1]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00617-6","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were approved according to the United States Public Health Service National Institutes of Health and Emory University Institutional Animal Care and Use Committee guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}